Biotage logo

Biotage

Azione
Azione
ISIN: SE0000454746
Ticker: BIOT
SE0000454746
BIOT

Price

Prezzo

GRAFICO PER

Dividendi storici e previsioni

 


0,114

GRAFICO PER

Domande frequenti

Biotage's Earnings Per Share (EPS) over the trailing twelve months (TTM) is 0,323. EPS indicates the company's profitability on a per-share basis.
Currently, 1 analysts cover Biotage's stock, with a consensus target price of 14,63 USD. Analyst ratings provide insights into the stock's expected performance.
Nei dodici mesi precedenti, Biotage ha registrato un fatturato di 197,91 Mln USD.
L'utile prima degli interessi, delle imposte, del deprezzamento e dell'ammortamento (EBITDA) di Biotage nei dodici mesi precedenti è pari a 47,13 Mln USD. L'EBITDA misura la performance finanziaria complessiva dell'azienda.
Biotage ha un flusso di cassa libero di 26,64 Mln USD. Il flusso di cassa libero indica la liquidità generata dopo aver contabilizzato i flussi di cassa in uscita per sostenere le operazioni e le attività di capitale.
Biotage impiega circa 673 persone. Opera nel settore Assistenza sanitaria, in particolare nell'industria Specialità mediche.

Dati finanziari

EPS (TTM) 
0,323
Ricavi (TTM) 
197,91 Mln USD
EBITDA (TTM) 
47,13 Mln USD
Flusso di cassa libero (TTM) 
26,64 Mln USD

Valutazioni degli analisti

L'obiettivo di prezzo è 14,63 USD e l'azione è coperta da 1 analisti.

Acquisto

0

Tenere

1

Vendita

0

Informazioni

Biotage AB is a Swedish life science company specializing in advanced laboratory technologies and workflow solutions that support drug discovery, development, and analytical testing to improve human health. The company is based in Uppsala, Sweden. The company offers a comprehensive portfolio of systems, consumables, reagents, and accessories focused on chemical synthesis, purification, evaporation, and sample extraction and clean-up. Product categories include organic and peptide synthesis, biomolecule purification, flash chromatography, solid-phase and supported liquid extraction, filtration, and evaporation technologies. Biotage provides automated sample preparation workstations, advanced peptide synthesizers, specialized solid-supported reagents, chromatography resins, prepacked columns, cartridges, and plates for various purification needs. The company's solutions are used in bioanalysis, forensic toxicology, environmental testing, food safety, doping control, and biomolecule purification, and are supported by knowledge resources, customer service, application support, and software tools. The company serves customers in pharmaceutical, biotech, contract research and manufacturing, clinical, forensic, academic laboratories, and organizations focused on food safety, clean water, and environmental sustainability. and has a global presence of subsidiaries in several regions. The company was founded in 1969 by Bengt Falk, Bertil Pettersson, Björn Lennart Ekström, Carl Erik Mathias Uhlén, Mostafa Ronaghi, Neil Goldsmith, Pal Nyrén, Sheridan G. Snyder. Frederic Vanderhaegen has been the CEO of the company since 2024.

Dipendenti
673
Industrie
Specialità mediche
Settore
Assistenza sanitaria

Identificatore

ISIN
SE0000454746
Ticker primario
BIOT

Knockouts

Dati LSX · Dati finanziari di FactSet
Partecipa alla conversazione